RxDoctor Payments Data

Lisa Holmes, MD

Family Medicine · Hinsdale, ILNPI 1871550798

Payments from drug & device makers

$6,735in general payments, 2019–2025

Across 279 payments — averaging $24.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Amgen$781
  • Lilly USA, LLC$596
  • Novo Nordisk$453
  • GSK$415
  • Gilead$350
  • plus $2K from 23 others

What the payments were for

  • Food & beverage$6,69899%
  • Education$371%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,735 in reported general payments places this provider in the 90th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$94,376
Medicare patients
213
Services billed
1,119

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide12$22,817
EliquisApixaban11$18,210
Icosapent Ethyl11$2,644
Nebivolol Hcl17$1,909
Levothyroxine Sodium145$1,865
Escitalopram Oxalate78$1,245
Atorvastatin Calcium123$1,202
Simvastatin83$1,110
Rosuvastatin Calcium73$1,010
Armour ThyroidThyroid,pork12$991
Lisinopril70$867
Venlafaxine Hcl ErVenlafaxine Hcl22$729
Amlodipine Besylate94$727
Irbesartan-HydrochlorothiazideIrbesartan/Hydrochlorothiazide19$723
Metformin Hcl ErMetformin Hcl49$710

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$596$22,81712 claims
PfizerEliquis$206$18,21011 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$14$1,865145 claims
AbbVieArmour Thyroid$1,796$99112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Hinsdale

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →